DE602005024554D1 - Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür - Google Patents

Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür

Info

Publication number
DE602005024554D1
DE602005024554D1 DE602005024554T DE602005024554T DE602005024554D1 DE 602005024554 D1 DE602005024554 D1 DE 602005024554D1 DE 602005024554 T DE602005024554 T DE 602005024554T DE 602005024554 T DE602005024554 T DE 602005024554T DE 602005024554 D1 DE602005024554 D1 DE 602005024554D1
Authority
DE
Germany
Prior art keywords
besilate
pharmaceutical composition
dihydrate
lisinopriled
amlodipin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005024554T
Other languages
German (de)
English (en)
Inventor
Akos Kelen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of DE602005024554D1 publication Critical patent/DE602005024554D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005024554T 2004-06-10 2005-06-09 Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür Expired - Lifetime DE602005024554D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0401170A HUP0401170A2 (en) 2004-06-10 2004-06-10 Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
PCT/HU2005/000064 WO2005120502A1 (en) 2004-06-10 2005-06-09 New pharmaceutical composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DE602005024554D1 true DE602005024554D1 (de) 2010-12-16

Family

ID=89985289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024554T Expired - Lifetime DE602005024554D1 (de) 2004-06-10 2005-06-09 Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür

Country Status (15)

Country Link
EP (1) EP1765342B9 (https=)
AT (1) ATE486599T1 (https=)
CY (1) CY1111484T1 (https=)
DE (1) DE602005024554D1 (https=)
DK (1) DK1765342T3 (https=)
EA (1) EA010288B1 (https=)
ES (1) ES2354618T3 (https=)
HR (1) HRP20110034T1 (https=)
HU (2) HUP0401170A2 (https=)
ME (1) ME01935B (https=)
PL (1) PL1765342T4 (https=)
PT (1) PT1765342E (https=)
RS (1) RS51677B (https=)
SI (1) SI1765342T1 (https=)
WO (1) WO2005120502A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790817A1 (en) * 2010-02-24 2011-09-01 Sanofi-Aventis Deutschland Gmbh Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
RU2483728C1 (ru) * 2011-09-29 2013-06-10 Общество с ограниченной ответственностью "Озон" Комбинированное гипотензивное средство и способ его получения
PL227900B1 (pl) * 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CN105194647A (zh) * 2014-06-30 2015-12-30 南京瑞尔医药有限公司 一种含有赖诺普利和苯磺酸氨氯地平的药物组合物及其制备方法
CN106333948A (zh) * 2016-08-23 2017-01-18 成都尚药科技有限公司 含有苯磺酸氨氯地平和二水合赖诺普利的药物及制备方法
WO2018200691A2 (en) 2017-04-25 2018-11-01 Proteus Digital Health, Inc. Lisinopril compositions with an ingestible event marker
GB2595203A (en) 2020-03-03 2021-11-24 Alkaloid Ad Skopje Formulation
CN119730841A (zh) * 2022-09-07 2025-03-28 拉塞·凯那司特 Api含量提高的氨氯地平的立即释放口服药物形式

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11500140A (ja) * 1995-03-16 1999-01-06 ファイザー・インコーポレーテッド アムロジピン、アムロジピン塩、もしくはフェロジピンとａｃｅ阻害薬とを含有する組成物
HUP0202416A3 (en) 2002-07-24 2006-01-30 Richter Gedeon Vegyeszet Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders

Also Published As

Publication number Publication date
EP1765342B9 (en) 2011-02-23
DK1765342T3 (da) 2011-01-24
PT1765342E (pt) 2010-12-20
RS51677B (sr) 2011-10-31
ES2354618T3 (es) 2011-03-16
EP1765342A1 (en) 2007-03-28
SI1765342T1 (sl) 2011-02-28
EP1765342B1 (en) 2010-11-03
ATE486599T1 (de) 2010-11-15
WO2005120502A1 (en) 2005-12-22
HUE009867T2 (https=) 2011-05-30
HUE009867T4 (hu) 2022-01-28
PL1765342T4 (pl) 2022-11-07
HU0401170D0 (en) 2004-08-30
EA010288B1 (ru) 2008-08-29
CY1111484T1 (el) 2015-08-05
HUP0401170A2 (en) 2006-09-28
ME01935B (me) 2011-10-31
PL1765342T3 (pl) 2011-04-29
HRP20110034T1 (hr) 2011-02-28
EA200602187A1 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
IL158589A (en) Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
FI20001696A7 (fi) Biologisesti aktiivinen materiaali
YU69603A (sh) Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
MY143795A (en) Tetrahydropyridoindole derivatives
BR0312000A (pt) Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos
BRPI0408439A (pt) composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético
CY1111484T1 (el) Φαρμακευτικη συνθεση που περιεχει αμλοδιπινη βεσυλικη και λισινοπριλη διυδρικη και μεθοδος παρασκευης αυτης
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
ID29025A (id) Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
PT1047413E (pt) Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
WO2023150790A3 (en) Novel and highly selective sars-cov-2 mpro inhibitors
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
PT1432407E (pt) Composicoes de lisinopril que possuem dcpd de particulas grandes
WO2004093827A3 (en) Phenolic acid salts of gabapentin in solid dosage forms and methods of use